Home » Topics » BioWorld Science

BioWorld Science
RSS

ADC Therapeutics begins dosing in registrational phase II trial evaluating ADCT-402

Aug. 8, 2018

Researchers present new anti-CRH MAb for AD downstream pathologies

Aug. 8, 2018

FDA expands approval of Orkambi to children 2 to 5 years of age

Aug. 8, 2018

Plant-derived compound silvestrol inhibits HEV replication with additive effect to ribavirin

Aug. 8, 2018

Neuroendocrine stress pathways mediate the adverse health effects of air pollution

Aug. 8, 2018

Sichuan Kelun-Biotech Biopharmaceutical patents FXR agonists

Aug. 8, 2018

NHRI synthesizes new CXCR4 ligands

Aug. 8, 2018

U.S. researchers identify ITGA5 antagonists

Aug. 8, 2018

Data analysis completed for second cohort in part I of phase I/IIa study of CRV-431

Aug. 8, 2018

Korean researchers divulge new antiviral compounds

Aug. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...